Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

Aastrom Biosciences, Inc. (ASTM)

4.29 0.07(1.61%) Apr 24, 4:00PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Aastrom Biosciences, Inc.
24 Frank Lloyd Wright Drive
Ann Arbor, MI 48105
United States - Map
Phone: 734-418-4400
Fax: 734-665-0485

Index Membership:N/A
Full Time Employees:40

Business Summary 

Aastrom Biosciences, Inc., a clinical-stage biotechnology company, focuses on the development of cell therapies for use in the treatment of severe chronic ischemic cardiovascular diseases. The company is developing a manufacturing technology platform, the Aastrom Replicell System, which enables the expansion of a various cell types, including the production of multicellular therapies expanded from an adult patientÂ’s own bone marrow that can be delivered directly to damaged tissues. Its lead product candidate include ixmyelocel-T, to treat patients with severe chronic ischemic cardiovascular diseases, such as advanced heart failure due to dilated cardiomyopathy, the third leading cause of heart failure, and critical limb ischemia. The company was founded in 1989 and is headquartered in Ann Arbor, Michigan.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Aastrom Biosciences, Inc.

Key Executives 
Mr. Dominick C. Colangelo Esq., 50
Chief Exec. Officer, Pres and Director
Mr. Michael W. Elliston , 34
Principal Fin. Officer, Chief Accounting Officer, Sec., Treasurer and Controller
Mr. Daniel R. Orlando , 49
Chief Operating Officer
Dr. Ronnda L. Bartel Ph.D., 55
Dr. Sharon M. Watling PharmD, 50
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders